|
Jeffrey S. Price, Ph.D., as President and CEO of Neurobiological Technologies Inc., Richmond, CA (until May, 1997), raised approximately $30 million, including an IPO in February 1994, and brought four products into phase II clinical trials. Dr. Price was formerly Senior Vice President of Research and Development at Cetus Corporation, (later acquired by Chiron Corporation, Emeryville, CA), where he directed a staff of approximately 500 scientists, engineers, physicians and support personnel. Two new therapeutic human proteins now on the market worldwide were developed under Dr. Price's management of Cetus' R&D. PCR DNA amplification, the only biotechnology company invention to result in a Nobel Prize, was also discovered and developed by Dr. Price's R&D team. He was a member of the executive management team at Cetus that raised approximately $500 million in financing. Dr. Price, a founder and director of PLANET, has extensive experience in several critical areas including business and technology management, drug development, operations and finance. He is also presently Chairman of the Board of Directors of Octamer, Inc., a company producing therapeutic drug products through conventional synthetic chemistry means. | 